Evogene Ltd (NYSE:EVGN)

10.00
Delayed Data
As of May 04
 0.00 / 0.00%
Today’s Change
8.07
Today|||52-Week Range
17.48
+8.58%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close10.00
Today’s open9.96
Day’s range-- - --
Volume10,634
Average volume (3 months)5,387
Market cap$253.6M
Dividend yield--
Data as of 05/04/2015

Growth & Valuation

Earnings growth (last year)-28.89%
Earnings growth (this year)-25.08%
Earnings growth (next 5 years)--
Revenue growth (last year)-17.46%
P/E ratio--
Price/Sales16.22
Price/Book2.18

Competitors

 Today’s
change
Today’s
% change
IKNXIkonics Corp+0.35+2.49%
CCMPCabot Microelectroni...+0.77+1.66%
KYTHKYTHERA Biopharmaceu...-0.15-0.33%
OCIPOCI Partners LP+0.18+0.97%
Data as of 05/04/2015

Financials

Next reporting dateMay 19, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$14.5M
Annual profit (last year)-$14.5M
Net profit margin-100.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Financial Officer
Sigal Fattal
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers